Articles & Press Releases

Society for Vascular Surgery Shows Need for Action: Vascular Disease Risk Projected to Double by 2030

WellSpan York Hospital receives national verification from the American College of Surgeons Vascular Verification Program

25 unprovoked shark attacks occurred in the U.S. in 2025; vascular surgeons call attention to a disease that contributes to approximately 400 limbs lost every day.

Founded on July 3, 1946, SVS celebrates its legacy of supporting vascular surgeons, strengthening the specialty and improving vascular health

Study Shows Lower Healthcare Costs, High Rates of Success, and Lower Risk of Infection

More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals

Study Finds Long-Term Stroke and Death Rates Favor Carotid Endarterectomy (CEA) over Carotid Artery Stenting (CAS) in Treating Patients with Asymptomatic Carotid Artery Stenosis 

Late-Breaking Data from EFFORT-2 Highlights the Life-Saving Benefits of Aerobic Exercise with Anticoagulation Therapies in Patients with Lower Extremity Deep Vein Thrombosis

Severe Lifestyle Limitation Documentation, Exercise Therapy, and Optimal Medical Therapy Decrease Major Adverse Limb Event Risk

 International gathering of more than 1,400 vascular specialists will feature the latest data on limb-threatening diseases, novel technology and integration of specialty within larger healthcare system  

Rosemont, Ill. – April 24, 2026 – The American College of Surgeons (ACS) and Society for Vascular Surgery (SVS) have verified three hospitals through the Vascular Verification Program (Vascular-VP).

In November 2025, the New England Journal of Medicine published data from the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Study (CREST-2) trial.

Updated guidance incorporates new research to address non-operative management of BTAI, timing of repair and the management of patients with concomitant traumatic injuries.

William H. Baker, M.D., a past president of the American Association for Vascular Surgery (AAVS) and a longtime contributor to the Society for Vascular Surgery (SVS), died Dec. 1.

Froedtert & MCW Froedtert Hospital receives national verification from the American College of Surgeons Vascular Verification Program

This article was sponsored by Philips. 

ROSEMONT, Ill. — In recognition of National Healthcare Quality Week, observed Oct.

Memorial Regional Hospital receives national verification from the American College of Surgeons Vascular Verification Program

Timely update comes as September marks Peripheral Artery Disease (PAD) Awareness Month

Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.

Following extended negotiations in both the House and Senate, Congress narrowly passed a major reconciliation package, titled the One Big, Beautiful Bill Act (OBBBA), on July 3, which was signed into law by President Trump on July 4.

Rosemont, Ill.  – The Society for Vascular Surgery (SVS) is pleased to announce the results of the 2025 elections for Vice President and Secretary, revealed today during the SVS Annual Business Meeting held as part of the Vascular Annual Meeting (VAM) in New Orleans, La.

Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).

A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.